We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+7.42%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$14.1B
AUM Growth
+$2.17B
Cap. Flow
+$1.47B
Cap. Flow %
10.47%
Top 10 Hldgs %
18.97%
Holding
1,309
New
346
Increased
287
Reduced
265
Closed
392

Top Buys

Rank Stock Value
1
ZTS icon
Zoetis
ZTS
+$177M
2
LOW icon
Lowe's Companies
LOW
+$108M
3
STJ
St Jude Medical
STJ
+$95.4M
4
NWL icon
Newell Brands
NWL
+$88.6M
5
STZ icon
Constellation Brands
STZ
+$87.2M

Top Sells

Rank Stock Value
1
EMC
EMC CORPORATION
EMC
+$136M
2
UNH icon
UnitedHealth
UNH
+$99.3M
3
PYPL icon
PayPal
PYPL
+$85.4M
4
SBUX icon
Starbucks
SBUX
+$78.1M
5
CI icon
Cigna
CI
+$64.7M

Sector Composition

Rank Sector Weight
1 Healthcare 20.63%
2 Consumer Discretionary 12.48%
3 Communication Services 12.09%
4 Technology 9.72%
5 Industrials 9.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CHGG icon
901
Chegg
CHGG
$108M
$128K ﹤0.01%
+18,044
New +$115K
LSAK icon
902
Lesaka Technologies
LSAK
$388M
$103K ﹤0.01%
12,015
-260,155
-96% -$2.57M
TRUE
903
DELISTED
TrueCar
TRUE
$103K ﹤0.01%
+10,892
New +$102K
CIE
904
DELISTED
Cobalt International Energy, Inc
CIE
$97K ﹤0.01%
5,221
+9
+0.2% +$167
TPST icon
905
Tempest Therapeutics
TPST
$14.8M
$79K ﹤0.01%
4
-81
-95% -$1.47M
MR
906
DELISTED
Montage Resources Corporation Common Stock
MR
$79K ﹤0.01%
1,592
-154,296
-99% -$7.38M
BTE icon
907
Baytex Energy
BTE
$3.08B
$76K ﹤0.01%
+17,940
New +$86.7K
ARRY
908
DELISTED
Array Biopharma Inc
ARRY
$75K ﹤0.01%
+11,129
New +$43K
SAN icon
909
Banco Santander
SAN
$194B
$68K ﹤0.01%
16,102
CLD
910
DELISTED
Cloud Peak Energy Inc
CLD
$64K ﹤0.01%
+11,702
New +$40.7K
AKS
911
DELISTED
AK Steel Holding Corp
AKS
$61K ﹤0.01%
12,668
-631,361
-98% -$3.2M
ONSIW
912
DELISTED
Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019
ONSIW
$60K ﹤0.01%
125,100
TRTLW
913
DELISTED
Terrapin 3 Acquisition Corporation
TRTLW
$36K ﹤0.01%
+200,000
New +$44K
AA icon
914
Alcoa
AA
$11.7B
-10,727
Closed -$239K
AAOI icon
915
Applied Optoelectronics
AAOI
$8.04B
-18,354
Closed -$205K
ABBV icon
916
AbbVie
ABBV
$458B
-11,479
Closed -$711K
ABEV icon
917
Ambev
ABEV
$47.3B
-39,062
Closed -$231K
ABG icon
918
Asbury Automotive
ABG
$4.19B
-16,397
Closed -$865K
ACIW icon
919
ACI Worldwide
ACIW
$5.72B
-63,196
Closed -$1.23M
ADI icon
920
Analog Devices
ADI
$181B
-35,964
Closed -$2.04M
ADSK icon
921
Autodesk
ADSK
$44.3B
-90,142
Closed -$4.88M
AEO icon
922
American Eagle Outfitters
AEO
$2.85B
-154,398
Closed -$2.46M
AGRO icon
923
Adecoagro
AGRO
$1.53B
-26,923
Closed -$295K
AIG icon
924
American International
AIG
$41.9B
-130,241
Closed -$6.89M
ALEX
925
DELISTED
Alexander & Baldwin
ALEX
-6,220
Closed -$225K

Similar funds

Marshall Wace's Q3 2016 Portfolio in Review

As of Q3 2016, Marshall Wace held 1,309 positions worth $14.1B, up 18% from $11.9B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Marshall Wace deployed $1.47B of net new capital in Q3 2016, opening 346 new positions and adding to 287 existing holdings. Its largest new stake was St Jude Medical: 1,181,595 shares worth $94.2M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was UnitedHealth, an estimated $99.3M trimmed.

  • Marshall Wace's largest Q3 2016 buy was St Jude Medical: 1,181,595 shares worth $94.2M.
  • Marshall Wace added most to Zoetis in Q3 2016, an estimated $177M increase.
  • Marshall Wace's biggest Q3 2016 reduction was UnitedHealth, cutting an estimated $99.3M.
  • Marshall Wace fully exited EMC CORPORATION in Q3 2016, selling an estimated $136M.
  • Marshall Wace's ten largest holdings make up 19% of its $14.1B portfolio in Q3 2016.
  • Marshall Wace opened 346 new positions and closed 392 in Q3 2016.
  • Marshall Wace's portfolio value rose 18% quarter-over-quarter to $14.1B.

Based on Marshall Wace's 13F filing for Q3 2016, filed 10 Nov 2016.